Australia markets closed

MEI Pharma, Inc. (MEIP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.1000-0.1600 (-4.91%)
At close: 04:00PM EDT
3.2100 +0.11 (+3.55%)
After hours: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
72,648
48,816
40,697
34,796
27,756
Cost of revenue
-
-
0
1,408
2,671
Gross profit
-
-
40,697
33,388
25,085
Operating expenses
Research development
25,071
52,450
85,641
69,398
34,065
Selling general and administrative
31,697
33,130
30,540
24,414
16,717
Total operating expenses
56,768
85,580
116,181
93,812
50,782
Operating income or loss
15,880
-36,764
-75,484
-60,424
-25,697
Total other income/expenses net
-19
1,581
20,746
18,608
-22,870
Income before tax
19,844
-31,838
-54,454
-41,306
-47,172
Income tax expense
-
-
0
8
1
Income from continuing operations
19,844
-31,838
-54,454
-41,314
-47,173
Net income
19,844
-31,838
-54,454
-41,314
-47,173
Net income available to common shareholders
19,844
-31,838
-54,454
-41,314
-47,173
Basic EPS
6.17
-4.78
-8.75
-7.40
-10.40
Diluted EPS
6.17
-4.78
-9.99
-12.00
-10.40
Basic average shares
6,663
6,663
6,224
5,626
4,554
Diluted average shares
6,663
6,663
6,257
5,724
4,554